Global Scholars Will Train at 10 Leading Avon Breast Cancer Crusade-funded U.S. Breast Cancer Centers

NEW YORK, NY (March 30, 2016) – In honor of National Doctors’ Day, the Avon Breast Cancer Crusade today announced its third class of Avon Global Breast Cancer Clinical Scholars, which will train breast cancer specialists living outside the United States at 10 leading Avon Breast Cancer Crusade-funded U.S. breast cancer centers. The 2016 Global Scholars class, consisting of 20 physicians from 14 countries, will begin their course of studies in the U.S. by joining mentors and leaders at a series of events, including AVON 39 The Walk to End Breast Cancer in Washington, D.C. on April 30.

The Avon Global Breast Cancer Clinical Scholars Program educates doctors through clinically-focused scholarship opportunities aimed at reducing the unacceptably high mortality rates from breast cancer in many countries around the world. The Avon Global Scholars will begin a four-week in breast cancer surgery, pathology, breast imaging (radiology), medical oncology, clinical trial design and community and public health at Avon Breast Cancer Crusade-funded breast cancer centers in the United States.

The intensive training program will culminate at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in June, where the scholars will attend educational sessions featuring world-renowned oncology professionals. The goal is for the scholars to return home with advanced skills and cutting edge information so they are better equipped to provide the highest quality of breast cancer care to patients in their home countries. Each scholar will also have the opportunity to participate in the Global Cancer Institute’s live online Global Tumor Boards, where a multidisciplinary team of doctors get together to discuss complex patient cases and to collaborate from different continents.

“As a leader in the field for 24 years, the Avon Breast Cancer Crusade is pleased to launch the third class of Avon Global Breast Cancer Clinical Scholars to help fuel further advancements to breast cancer research, treatment and access to care globally,” said Carolyn Ricci, program director of the Avon Breast Cancer Crusade. “Each one of our Scholars is a real ambassador for change in their home country. Right now, 47 Global Scholars who studied in the U.S. in 2012 and 2014 are back at home applying new advanced skills to help save tens of thousands of lives throughout the world.”

“The Global Scholars are exposed to state–of–the–art clinical practices and research initiatives, and they hone their skills by interacting with some of the best clinicians and researchers in the U.S.,” says Dr. Goss, Avon Breast Cancer Crusade Scientific Advisory Board Chair and Chief Mission Officer of the Global Cancer Institute. “The Avon Global Breast Cancer Clinical Scholars Program gives Scholars the tools they need to continue access-to-care work in their home countries by implementing global patient navigation projects, participating in research analyses and publications on the overall state of breast cancer control, and creating lasting connections with a large community of US oncologists and global doctors that will help them improve care for their patients back home. Our goal at Massachusetts General Hospital (MGH) is to keep the Avon-MGH Scholars connected both professionally and personally so they can improve the survival and quality of life of underserved patients and create a meaningful impact, and we have a great track record doing this.”
The Avon Breast Cancer Scientific Advisory Board and host institution mentors evaluated the applications and their recommendations were sent to the Avon Breast Cancer Crusade Board of Managers who made the final scholar selections. To date, the Avon Global Scholars program has received nearly 300 applications from 55 countries, of which 68 Scholars from 26 countries – from Armenia to Zambia – were selected for the program. The third Avon class includes breast cancer specialists from Algeria, Argentina, Armenia, Brazil, Colombia, Croatia, Nigeria, Philippines, Romania, Serbia, Tanzania, Turkey, and Zimbabwe will be studying at the following Avon Breast Cancer Crusade-funded breast cancer programs:

  • Baylor College of Medicine, Houston
  • Boston Medical Center, Boston, Mass.
  • Cedars- Sinai Medical Center, Los Angeles
  • Emory University, Atlanta
  • John Hopkins University, Baltimore, Md.
  • Houston Methodist, Houston
  • Massachusetts General Hospital, Boston, Mass.
  • Northwestern University, Chicago, Ill.
  • New York-Presbyterian Hospital-Columbia University Medical Center, New York
  • San Francisco General Hospital, San Francisco

Avon Breast Cancer Crusade

The Avon Breast Cancer Crusade has placed Avon at the forefront of the fight against breast cancer. Today, Avon is the leading corporate supporter of the cause globally. Since Avon launched the Crusade in 1992, Avon breast cancer programs in over 50 countries have contributed more than $800 million to conduct research and advance access to quality care for all, regardless of a person’s ability to pay. Avon awards funding to beneficiaries ranging from leading cancer centers to community-based grassroots breast health programs to support breast cancer research and access to care. The Crusade has enabled more than 18 million women globally to receive free mammograms and breast cancer screenings, educated more than 145 million women about breast cancer, and funded promising research into the causes of breast cancer and ways to prevent the disease. Avon and the Avon Breast Cancer Crusade raise funds through the sale of Avon “Pink Ribbon” products and through fundraising events over 50 countries annually, including the U.S. AVON 39 The Walk to End Breast Cancer series and the Avon Walk Around the World to End Breast Cancer events.

##